Literature DB >> 9153462

Predictors of time to institutionalization of patients with Alzheimer's disease: the CERAD experience, part XVII.

A Heyman1, B Peterson, G Fillenbaum, C Pieper.   

Abstract

We studied the time to institutionalization (or death as the first event) in 727 white patients with Alzheimer's disease (AD) enrolled in the Consortium to Establish a Registry for Alzheimer's disease (CERAD). At the time of analysis, 417 patients had been admitted to nursing homes and 32 others had died without previous institutionalization. The major predictors of time to first event were sex, age, marital status (men only), and severity of dementia at entry into the study, as measured by activities of daily living, the Mini-Mental State Examination, and the Clinical Dementia Rating scale. The overall median time from enrollment in the study to first event was 3.1 years. For unmarried men, the median time was significantly less (2.1 years) than for either married men or for married or unmarried women, all of whom had medians greater than 3 years. In an analysis of survival time following institutionalization, we found that men survived a median of 2.1 years, compared with 4.5 years for women. This nationwide study of AD largely confirms earlier studies that reported on smaller numbers of cases from local catchment areas and included patients with various types of dementia.

Entities:  

Mesh:

Year:  1997        PMID: 9153462     DOI: 10.1212/wnl.48.5.1304

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  20 in total

1.  Modelling the cost effectiveness of cholinesterase inhibitors in the management of mild to moderately severe Alzheimer's disease.

Authors:  Nick Bosanquet; Andrew Yeates
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

2.  Repetition priming and change in functional ability in older persons without dementia.

Authors:  Debra A Fleischman; Julia L Bienias; David A Bennett
Journal:  Neuropsychology       Date:  2009-01       Impact factor: 3.295

3.  Stability and changes in living arrangements: relationship to nursing home admission and timing of placement.

Authors:  Judith D Kasper; Liliana E Pezzin; J Bradford Rice
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2010-05-04       Impact factor: 4.077

Review 4.  Rivastigmine. A pharmacoeconomic review of its use in Alzheimer's disease.

Authors:  H M Lamb; K L Goa
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

5.  Living with and caring for patients with Alzheimer's disease in nursing homes.

Authors:  Shahrzad Yektatalab; Farkhondeh Sharif; Mohammad Hossein Kaveh; Masood Fallahi Khoshknab; Peyman Petramfar
Journal:  J Caring Sci       Date:  2013-08-27

6.  The Association Between Activity Limitation Stages and Admission to Facilities Providing Long-term Care Among Older Medicare Beneficiaries.

Authors:  Jibby E Kurichi; Joel E Streim; Dawei Xie; Sean Hennessy; Ling Na; Debra Saliba; Qiang Pan; Pui L Kwong; Hillary R Bogner
Journal:  Am J Phys Med Rehabil       Date:  2017-07       Impact factor: 2.159

Review 7.  Systematic Review of Model-Based Economic Evaluations of Treatments for Alzheimer's Disease.

Authors:  Luis Hernandez; Asli Ozen; Rodrigo DosSantos; Denis Getsios
Journal:  Pharmacoeconomics       Date:  2016-07       Impact factor: 4.981

8.  Sleep pattern differences between older adult dementia caregivers and older adult noncaregivers using objective and subjective measures.

Authors:  Meredeth A Rowe; Christina S McCrae; Judy M Campbell; Andrea Pe Benito; Jing Cheng
Journal:  J Clin Sleep Med       Date:  2008-08-15       Impact factor: 4.062

9.  The relation of patient dependence to home health aide use in Alzheimer's disease.

Authors:  Rachel K Scherer; Nikolaos Scarmeas; Jason Brandt; Deborah Blacker; Marilyn S Albert; Yaakov Stern
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2008-09       Impact factor: 6.053

10.  Evaluation of the validity and reliability of the Alzheimer Disease-related Quality of Life Assessment Instrument.

Authors:  Judith D Kasper; Betty S Black; Andrew D Shore; Peter V Rabins
Journal:  Alzheimer Dis Assoc Disord       Date:  2009 Jul-Sep       Impact factor: 2.703

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.